We’ve been waiting on this one for three years. If you’ve frequented this blog, you know three years is basically an eternity in Food and Drug Administration (FDA) years but…
If an employee uses marijuana off the clock and the employer doesn’t test for marijuana, isn’t it much like the tree falling in the woods?
A recent Wall Street Journal…
Raising money in the cannabis industry, like most everything else in the space, is no walk in the park and presents a landmine for those tasked with raising and spending…
At some point over the course of each year, we like to take stock of where psychedelics stand — our own version of a trip around the sun. The…
If you’ve followed Budding Trends for any length of time, you know the SAFE Banking Act — perhaps second only to rescheduling — has been the white whale for marijuana…
I don’t know why I write things that encourage people to take my job. I’ll add that to the list for my next therapy session.
Back in 2022, I wrote…
The April order rescheduling DEA-approved medications and state-licensed medical marijuana to Schedule III set off a scramble in the capital markets. Two questions sit at the center of it: Can…
If you were hoping the South Carolina governor’s race might crack open the door for a state medical marijuana program — or settle the state’s running fight over intoxicating hemp…
In The Usual Suspects, Verbal Kint explains the final reveal of the film, and I stress the world “film”: “The greatest trick the devil ever pulled was convincing the…
President Trump has announced he will nominate Todd Blanche — his former personal attorney, who has been running the Department of Justice in an acting capacity — to serve as…